# Nanophase Technologies Corporation – FDA Inspection, Apr 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/22d2e70e-237e-4e93-9811-df1e87ad4563
Source feed: FDA_Inspections

> FDA inspection 1205286 of Nanophase Technologies Corporation, April 13, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1205286
- Company Name: Nanophase Technologies Corporation
- Inspection Date: 2023-04-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1298600 - 2026-01-09](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/15d88410-e532-46d7-80a1-b982caf658e5)
- FDA Inspection 1096141 - 2019-06-07
- FDA Inspection 1077501 - 2018-11-29
- FDA Inspection 896947 - 2014-09-15
- FDA Inspection 753672 - 2011-11-17

## Related Officers

- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)

Company: https://www.keypedia.com/companies/nanophase-technologies-corporation/2b2b4bbe-7d35-4ece-8a79-dbffc6f82a51

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
